Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07553468
NA

Stromal Vascular Cells for the Treatment of Diabetic Peripheral Neuropathy

Sponsor: Michael H Carstens

View on ClinicalTrials.gov

Summary

This is an interventional open-label study to determine the safety and clinical performance of SVF cells in the treatment of Diabetic Peripheral Neuropathy.

Official title: Treatment of Diabetic Peripheral Neuropathy With Adipose-derived Stromal Vascular Fraction Cells

Key Details

Gender

All

Age Range

30 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

8

Start Date

2024-12-01

Completion Date

2026-03-31

Last Updated

2026-04-28

Healthy Volunteers

No

Interventions

BIOLOGICAL

Adipose-derived Stromal Vascular Fraction Cells

Administration to the DFU / ankle was performed at four injection sites: 1. 20 cc into the wound bed 2. 20 cc subcutaneously around the perimeter of the wound 3. 10 cc along the tibialis posterior pathway at the ankle prior to entry into the plantar surface 4. 10 cc along the tibialis anterior / dorsalis pedis pathway from the ankle to the dorsum of the foot.

Locations (1)

Hospital Escuela Oscar Danilo Rosales Argüello

León, León Department, Nicaragua